T. Haruta et al., LIGAND-INDEPENDENT GLUT4 TRANSLOCATION INDUCED BY GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE) INVOLVES TYROSINE PHOSPHORYLATION, Endocrinology, 139(1), 1998, pp. 358-364
To delineate the signaling pathway leading to glucose transport protei
n (GLUT4) translocation, we examined the effect of microinjection of t
he nonhydrolyzable GTP analog, guanosine 5'-O-(3-thiotriphosphate) (GT
P gamma S), into 3T3-L1 adipocytes. Thirty minutes after the injection
of 5 mM GTP gamma S, 40% of injected cells displayed surface GLUT4 st
aining indicative of GLUM translocation compared with 55% for insulin-
treated cells and 10% in control IgG-injected cells. Treatment of the
cells with the phosphatidylinositol 3-kinase inhibitor wortmannin or c
oinjection of GST-p85 SH2 fusion protein had no effect on GTP gamma S-
mediated GLUT4 translocation. On the other hand, coinjection of antiph
osphotyrosine antibodies (PY20) blocked GTP gamma S-induced GLUT4 tran
slocation by 65%. Furthermore, microinjection of GTP gamma S led to th
e appearance of tyrosine-phosphorylated proteins around the periphery
of the plasma membrane, as observed by immunostaining with PY20. Treat
ment of the cells with insulin caused a similar phosphotyrosine-staini
ng pattern. Electroporation of GTP gamma S stimulated 2-deoxy-D-glucos
e transport to 70% of the extent of insulin stimulation. In addition,
immunoblotting with phosphotyrosine antibodies after electroporation o
f GTP gamma S revealed increased tyrosine phosphorylation of several p
roteins, including 70- to 80-kDa and 120- to 130-kDa species. These re
sults suggest that GTP gamma S acts upon a signaling pathway either do
wnstream of or parallel to activation of phosphatidylinositol 3-kinase
and that this pathway involves tyrosine-phosphorylated protein(s).